IL-15 in the Combination Immunotherapy of Cancer.

Waldmann, Thomas A; Dubois, Sigrid; Miljkovic, Milos D; Conlon, Kevin C

Waldmann, Thomas A; Dubois, Sigrid; Miljkovic, Milos D; Conlon, Kevin C.

Affiliation

Waldmann TA; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Dubois S; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Miljkovic MD; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Conlon KC; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Front Immunol ; 11: 868, 2020.

Article in En | MEDLINE | ID: mdl-32508818

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/therapeutic use; Immunotherapy; Interleukin-15/therapeutic use; Neoplasms/therapy; Animals; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Interleukin-15/administration & dosage; Mice; Signal Transduction

Key words

CD8 T cells; immunological checkpoints; immunotherapy of cancer; interleukin-15; natural killer cells

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-15 / Immunotherapy / Antibodies, Monoclonal / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: United States Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google